Litcius/Paper detail

Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa

Glenda Gray, Shirley Collie, Ameena Goga, Nigel Garrett, Jared Champion, Ishen Seocharan, Lesley Bamford, Harry Moultrie, Linda‐Gail Bekker

2022New England Journal of Medicine100 citationsDOIOpen Access PDF

Topics & Concepts

BusinessSARS-CoV-2 and COVID-19 ResearchViral Infections and Outbreaks ResearchVaccine Coverage and Hesitancy
Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa | Litcius